| Lung nodule characterisation with deep learning |
Julia Schnabel |
Kings College London |
NLST |
Nov 19, 2018 |
NLST-454 |
| Lung nodule screening on CT images |
Charubutr Asavaroengchai |
A.I.Brain Co., Ltd |
NLST |
Nov 19, 2018 |
NLST-453 |
| Diet, Metabolic Biomarkers and Lung Cancer Risk |
Martin Carl Tammemagi |
Brock University |
PLCO |
Nov 19, 2018 |
PLCO-418 |
| Artificial Intelligence -based Computer Aided Early Diagnosis for low dose CT scans |
Jolu Ninan |
Abu Dhabi University |
NLST |
Nov 19, 2018 |
NLST-450 |
| Establishing Equivalence of Commonly Used Physical Activity Measures Using Testing Equating |
Zezhao Chen |
University of Illinois at Urbana Champaign |
IDATA |
Nov 13, 2018 |
IDATA-28 |
| Public Policy Recommendations Towards Colorectal Screenings |
Robert Henderson |
George Mason University |
PLCO |
Nov 13, 2018 |
PLCO-422 |
| Evaluating genetic, clinical, and environmental risk factors for second primary lung cancer |
Summer Han |
Stanford University |
PLCO |
Nov 13, 2018 |
PLCO-423 |
| Levels of Trimethylamine Metabolites and Their Associations with Dietary Intakes and Cardiometabolic Biomarkers: the TMAO Pooling Project |
Danxia Yu |
Vanderbilt University Medical Center |
PLCO |
Nov 2, 2018 |
PLCO-414 |
| Predictors of second primary cancers among patients diagnosed with lung cancer in the PLCO trial |
Omar Abdel-Rahman |
Avicenna Oncology center |
PLCO |
Nov 2, 2018 |
PLCO-417 |
| Future diagnosis prediction of lung cancer using convolutional and recurrent networks. |
Latifur Khan |
University of Texas at Dallas |
NLST |
Oct 31, 2018 |
NLST-449 |
| Long Term Outcomes in Active Smokers Undergoing Lung Resection: An Analysis of the National Lung Cancer Screening Trial |
Joanna Sesti |
Robert Wood Johnson Barnabas Health |
NLST |
Oct 26, 2018 |
NLST-448 |
| Lung Cancer Risk Prediction Modelling -- Extensions to the PLCOm2012 model |
Martin Carl Tammemagi |
Brock University |
PLCO |
Oct 26, 2018 |
PLCO-416 |
| Clinical Cancer Data Analysis |
Canan Eren |
New Jersey Institute of Technology |
PLCO |
Oct 26, 2018 |
PLCO-410 |
| Serum Metabolomic Profiling of Glioma Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Jiaqi Huang |
NIH |
PLCO |
Oct 23, 2018 |
2017-1017 |
| Physical activity, PSA levels, and screen-detected prostate cancers. |
Yelena Tarasenko |
Georgia Southern University |
PLCO |
Oct 23, 2018 |
PLCO-415 |
| The role of environmental and socioeconomic factors in urologic malignancies |
Bashir Al Hussein |
New York Presbyterian Hospital |
NLST |
Oct 16, 2018 |
NLST-446 |
| The use of data from Food Frequency Questionnaire (FFQ) for network analysis on cancer survivorship and food intake |
Linghan Qian |
Tufts University |
PLCO |
Oct 15, 2018 |
PLCO-405 |
| Monitoring with Repeatedly Measured Markers: Application to longitudinal PSA measurements in PLCO |
Paramita Saha-Chaudhuri |
McGill University |
PLCO |
Oct 12, 2018 |
PLCO-408 |
| Impact of colorectal cancer sidedness on the outcomes of colorectal cancer patients diagnosed within PLCO study |
Omar Abdel-Rahman |
Avicenna Oncology center |
PLCO |
Oct 12, 2018 |
PLCO-407 |
| Outcomes of stage I non-small cell lung cancer patients treated with surgery versus radiation therapy within the NLST |
Omar Abdel-Rahman |
Avicenna Oncology center |
NLST |
Oct 11, 2018 |
NLST-445 |
